Johns Hopkins Health Alert
In the Pipeline: ANXA3 to screen for Prostate Cancer
UPDATE
As part of our ongoing effort to ensure that this website is up to date, we have determined that the information in the article In the Pipeline: ANXA3 to Screen for Prostate Cancer is no longer current, and has therefore been removed.
Thank you.
Posted in Prostate Disorders on July 15, 2010
Reviewed February 2011
Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer
Notify Me
Would you like us to inform you when we post new Prostate Disorders Health Alerts?
Comments
Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.
The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.
I had the new urine test done in January 2010 and the results indicated that I had with a 75% degree of accuracy, a 95% chance that I had Prostate Cancer. I then had a 24 pin prostate biopsy and indicated that I had no cancer. I felt the 24 pin not only was painful, but unnecessary all brought on by the ANAX3 test. The actual test I had was the PSA3+ test, is this the same as the ANAX3 test?
Posted by: richardd2102 | July 15, 2010 4:03 PM
Post a Comment
Already a subscriber?
Login
New to Johns Hopkins Health Alerts?
What am I missing here? The ANXA3 missed the cancer 50% of the time, but is celebrated for reducing false positives? I'm confused. It's great that false positives and subsequent unnecessary biopsies are avoided, but is that the focus for this test? Or is it in such an early stage that the researchers goal is for a much higher positive identification of prostate cancer?
Posted by: BobP | July 15, 2010 6:21 AM